Detalhe da pesquisa
1.
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
BMC Med
; 22(1): 9, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191387
2.
Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases.
J Med Genet
; 60(4): 327-336, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36137616
3.
Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.
Breast Cancer Res
; 25(1): 53, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37161532
4.
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.
Breast Cancer Res
; 25(1): 72, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37340476
5.
Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study.
J Med Genet
; 59(12): 1196-1205, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36162852
6.
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence.
J Med Genet
; 59(12): 1206-1218, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36162851
7.
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients.
Breast Cancer Res
; 24(1): 69, 2022 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36271417
8.
Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
Cancer
; 128(24): 4285-4295, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36281718
9.
Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study.
Breast Cancer Res Treat
; 194(1): 159-170, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507134
10.
Towards implementation of comprehensive breast cancer risk prediction tools in health care for personalised prevention.
Prev Med
; 159: 107075, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35526672
11.
Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017.
Int J Cancer
; 148(9): 2289-2303, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33252836
12.
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast.
Br J Cancer
; 125(10): 1443-1449, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34408284
13.
Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model.
Breast Cancer Res Treat
; 189(3): 817-826, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34338943
14.
Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.
Blood
; 133(10): 1130-1139, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573632
15.
The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancer.
Int J Cancer
; 146(8): 2296-2304, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31901133
16.
Breast cancer risk factors and their effects on survival: a Mendelian randomisation study.
BMC Med
; 18(1): 327, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33198768
17.
Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort.
Genet Med
; 22(11): 1803-1811, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32624571
18.
Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes.
Breast Cancer Res
; 21(1): 90, 2019 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31391067
19.
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.
Am J Hum Genet
; 99(4): 903-911, 2016 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27640304
20.
Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.
Ann Surg
; 270(2): 364-372, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29727326